Categories AlphaGraphs, Earnings, Health Care

Infographic: Key financials of Biogen (BIIB) Q2 2020 earnings report

Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of 2020. Adjusted EPS of $10.26 and revenue of $3.68 billion in the quarter were better than analysts’ estimates. Shares of Biogen rose about 3% in the pre-market trading session.

While Biogen lifted its EPS guidance for fiscal 2020, it lowered the revenue expectations.

Biogen (BIIB) Q2 2020 Earnings Infograph

The company lifted FY20 GAAP EPS outlook to a range of $32.00 and $34.00 from the prior guidance range of $29.50 to $31.50. Non-GAAP EPS is now expected to be between $34.00 and $36.00 versus a prior range of $31.50 to $33.50.

Revenue outlook for FY20 is cut down to a range of $13.8 billion to $14.2 billion from the prior expected range of $14.0 billion to $14.3 billion.

Read the entire transcript of Biogen Q2 2020 earnings call

Most Popular

Netflix (NFLX): Four reasons why this leader will not be easy to overthrow

Netflix (NASDAQ: NFLX) has for long been the undisputed king of the streaming space. The streaming industry is seeing massive growth with several new players entering the field. It also

Fastenal (FAST) sees strong post-COVID prospects: Is the stock a buy?

The demand for services that involve minimal human interaction is on the rise as people continue to practice social distancing. Fastenal Co. (NASDAQ: FAST), a market-leading supplier of vending machines,

HEXO Corp. (HEXO) Earnings: 3Q21 Key Numbers

HEXO Corp. (NYSE: HEXO) reported its third-quarter 2021 earnings results today. Net revenue rose 2% year-over-year to CAD22.6 million. Net loss narrowed to CAD20.7 million from a loss of CAD19.5

Add Comment
Viewing Highlight